Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease

S P McIlroy, K B Dynan, B M McGleenon, J T Lawson, A P Passmore

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

It has recently been reported that a genetic polymorphism in exon 2 of the cathepsin D gene conferred increased risk for development of Alzheimer's disease (AD). Because of the potential importance of this report we tested this association in a clinically well-defined group of AD patients and age and sex matched control subjects from the relatively genetically homogeneous Northern Ireland population. This study failed to confirm the reported association between the cathepsin D exon 2 polymorphism and AD. We conclude that if an association exists between this polymorphism and AD it is likely to be small.
Original languageEnglish
Pages (from-to)140-1
Number of pages2
JournalNeuroscience Letters
Volume273
Issue number2
Publication statusPublished - 1999

Fingerprint Dive into the research topics of 'Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease'. Together they form a unique fingerprint.

  • Cite this

    McIlroy, S. P., Dynan, K. B., McGleenon, B. M., Lawson, J. T., & Passmore, A. P. (1999). Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease. Neuroscience Letters, 273(2), 140-1.